Insel Gruppe AG, University Hospital Bern: Diabetes Mellitus, Type 1 trials
The registry lists 15 Diabetes Mellitus, Type 1 studies with Insel Gruppe AG, University Hospital Bern as lead sponsor. 0 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 3 2No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The HEADWIND Study - Part 4CompletedNCT05308095Not applicable
- The HEADWIND Study - Part 3CompletedNCT05183191Not applicable
- The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in DiabetesCompletedNCT04689685
- Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 DiabetesCompletedNCT04671043Not applicable
- The HEADWIND Study - Part 2CompletedNCT04569630Not applicable
- Role of the Liver in Glucose Homeostasis Using Metabolic ImagingCompletedNCT04352738
- Micro Glucagon During Exercise in Type 1 DiabetesWithdrawnNCT04192019Early Phase 1
- Dapagliflozin in Physical Exercise in Type 1 DiabetesCompletedNCT04049110Phase 3
- The HEADWIND-StudyCompletedNCT04035993Not applicable
- Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 DiabetesCompletedNCT04035031Phase 3
- The OpenAPS_ShadowMode StudyTerminatedNCT03720080
- Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin DegludecCompletedNCT03497260Not applicable
- Carbohydrate Estimation Supported by the GoCARB SystemCompletedNCT02546063Not applicable
- Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 DiabetesCompletedNCT02068638Not applicable
- The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes MellitusCompletedNCT00325559Not applicable